Biotech Sector Shows No Signs of Slowing — OXiGENE and Generex Poised for Growth – PR-USA.net

In 2011, regulators approved 13 new biotech products and major R&D milestones were reached all while the industry’s revenues and profits exceeded market expectations, BB observes. Global Industry Analysts, Inc. (GIA) says that improving economic conditions …